Influenza Diagnosis & Treatment
The Association of Medical Microbiology and Infectious Disease Canada (AMMI) has developed an “Influenza Information and Treatment” app. The app is called “AMMI Flu” and it is available at the apple store. The app has information intended for healthcare practitioners in Canada. It addresses antiviral drugs in the management of influenza illness.
For both zanamivir and oseltamivir, these guidelines are recommending some off-label applications that are not approved by Health Canada. Accordingly, it remains incumbent on the prescribing clinician to apprise the patient that the drug has not been approved for this indication. Physicians are strongly advised to use clinical judgment when assessing patients and making treatment decisions.
For complete recommendations, download the guidelines from the AMMI Canada website.
Health care providers play an important role in preventing the spread of influenza. As a health care provider, you can help your patients make an informed decision about influenza immunization.
It’s important to recommend the flu shot to all of your eligible patients. Research shows:
- When health care providers recommend a flu shot, patients are more likely to get one. Eight out of 10 people take their physician’s advice and get immunized.
- When health care providers get a flu shot, they reduce the risk of passing on the virus to patients, especially vulnerable people who are more at risk of complications.
- Influenza Vaccine Fact Sheets (MOHLTC)
- Health Care Provider Q & A
- Information for Physicians
- Information for Pharmacies
- Information for Long-Term Care Homes
- National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2017-2018
- Product Monographs
Components of 2017-2018 influenza vaccine
The periodic replacement of viruses contained in influenza vaccines is necessary in order for the vaccines to be effective due to the constant evolving nature of influenza viruses, including those circulating and infecting humans.
The World Health Organization (WHO) recommends that trivalent vaccines for use in the 2017-2018 influenza season (northern hemisphere winter) contain the following:
- an A/Michigan/45/2015 (H1N1)pdm09-like virus;
- an A/Hong Kong/480½014 (H3N2)-like virus; and
- a B/Brisbane/60/2008-like virus.
Pharmacies: Contact your flu vaccine distributor